Daniel Y. Lee, MD, PhD

Medicine & Life Sciences

1. R-Loop Structures 100%
2. T-Lymphocytes 67%
3. Mitochondrial DNA 65%
4. Neoplasms 60%
5. Nanoparticles 57%
6. Human Herpesvirus 4 56%
7. Lymphoma 55%
8. Replication Origin 51%
9. Ribonucleases 46%
10. Gold 42%
11. Integrins 39%
12. Molecular Imaging 38%
13. RNA primers 38%
14. Copper-64 37%
15. Theranostic Nanomedicine 36%
16. Mitochondrial RNA 35%
17. Tumor Escape 27%
18. DNA Primers 27%
19. DNA Replication 26%
20. Systemic Inflammatory Response Syndrome 25%
21. Membrane Proteins 25%
22. Radiopharmaceuticals 24%
23. Vascular Endothelial Growth Factor Receptor 24%
24. Genomics 24%
25. Hodgkin Disease 24%
26. Systems Analysis 23%
27. CY5.5 cyanine dye 22%
28. Positron Emission Tomography Computed Tomography 22%
29. Cytotoxic T-Lymphocytes 22%
30. RNA 21%
31. Precursor Cell Lymphoblastic Leukemia-Lymphoma 20%
32. Antigens 19%
33. Neoplasm Antigens 19%
34. Positron-Emission Tomography 19%
35. Protein-Tyrosine Kinases 18%
36. Inhibitory Concentration 50 18%
37. Evaluation Studies 18%
38. Epigenomics 18%
39. Multicenter Studies 18%
40. Therapeutics 17%
41. Mitochondria 17%
42. Chimeric Antigen Receptors 16%
43. Electrons 16%
44. N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine 16%
45. Antibodies 16%
46. Transforming Growth Factors 14%
47. DNA 14%
48. Magnetic Resonance Imaging 13%
49. Pharmaceutical Preparations 12%
50. Modern 1601-history 12%